Reduction in mortality and teratogenicity following simultaneous administration of folic acid and vitamin E with antiepileptic, antihypertensive and anti-allergic drugs

The present study was designed to evaluate the teratogenic effects on breeding pattern in mice following administration of lamotrigine (LT) and levetiracetam (LV) and its combination with anti-hypertensive and anti-allergic drugs. Moreover, possibility of decrease in teratogenic effect was also eval...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmacy & bioallied science 2014-07, Vol.6 (3), p.185-191
Main Authors: Wahid, Shahana, Khan, Rafeeq Alam, Feroz, Zeeshan
Format: Article
Language:English
Subjects:
Allergies
Anticonvulsants
Antiepileptic drugs
Behavior
Births
Cell division
Defects
Deoxyribonucleic acid
DNA
Dosage and administration
Drug dosages
Fetuses
Folic acid
Free radicals
Growth rate
Health aspects
Laboratory animals
Original
Pregnancy
Pregnant women
Studies
teratogenicity
Vitamin B
Vitamin E
Womens health
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The present study was designed to evaluate the teratogenic effects on breeding pattern in mice following administration of lamotrigine (LT) and levetiracetam (LV) and its combination with anti-hypertensive and anti-allergic drugs. Moreover, possibility of decrease in teratogenic effect was also evaluated upon simultaneous administration of these combinations with folic acid or vitamin E. The study was carried out on mature female mice housed in polycarbonate breeding cages. Drugs were administered continuously till the birth of neonates and pups were examined for any teratogenic potential of drugs. The results of the study reveals that teratogenic effects of lamotrigine, methyldopa and loratadine (LTMLO) combination were seems to be reduced upon simultaneous administration with folic acid, while addition of vitamin E was found to be more effective in reducing the mortality rate of levetiracetam, methyldopa and loratadine combination. Teratogenic effects of LTMLO combination were better prevented by folic acid. However, further studies on large number of animals and humans are required before reaching to definite conclusion.
ISSN:0976-4879
0975-7406
0975-7406
0976-4879
DOI:10.4103/0975-7406.130955